【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 7
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade’s Disease) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade’s Disease) to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade’s Disease) to Metabolic Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade’s Disease) Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade’s Disease) 30
Jul 11, 2013: Alnylam Reports Positive Top-Line Results for ALN-TTRsc, a Subcutaneously Administered RNAi Therapeutic Targeting Transthyretin for the Treatment of TTR-Mediated Amyloidosis 30
Mar 18, 2013: Alnylam Initiates Phase I Clinical Study For ALN-TTRsc For Treatment Of TTR-Mediated Amyloidosis 31
Feb 19, 2013: Isis Pharma Initiates Phase II/III Study Of ISIS-TTR Rx And Earns $7.5m Milestone Payment From GlaxoSmithKline 31
Aug 06, 2012: Alnylam Pharma Presents New Preclinical Data From ‘Alnylam5x15’ Programs Including ALN-TTRsc For Treatment Of Transthyretin-Mediated Amyloidosis 32
Jul 16, 2012: Alnylam Reports Positive Phase I Trial Results Of ALN-TTR02 For Treatment Of TTR-Mediated Amyloidosis 33
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Alnylam Pharmaceuticals, Inc. 36
Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 36
Isis Pharmaceuticals, Inc. 37
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Clinical Trial Overview of Top Institutes / Government 39
Umea University 39
Clinical Trial Overview of Umea University 39
Shinshu University 40
Clinical Trial Overview of Shinshu University 40
Boston University 41
Clinical Trial Overview of Boston University 41
Ospedale Policlinico San Matteo 42
Clinical Trial Overview of Ospedale Policlinico San Matteo 42
Brigham and Women’s Hospital 43
Clinical Trial Overview of Brigham and Women’s Hospital 43
Kumamoto University 44
Clinical Trial Overview of Kumamoto University 44
IRCCS Policlinico San Matteo 45
Clinical Trial Overview of IRCCS Policlinico San Matteo 45
Five Key Clinical Profiles 46
Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 98
Secondary Research 98
About GlobalData 99
Contact Us 99
Disclaimer 99
Source 99
【レポート販売概要】
■ タイトル：Familial Amyloid Polyneuropathy：治療薬のグローバル治験動向（2014年上半期）■ 英文：Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Global Clinical Trials Review, H1, 2014
■ 発行日：2014年5月15日
■ 調査会社：GlobalData
■ 商品コード：GDHC2136CTIDB
■ 調査対象地域：グローバル
- 人工内耳の世界市場分析：装着方法別（片耳用、両耳用）、エンドユーザー別（大人、小児）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA）、セグメント予測、2014-2025The global cochlear implants market is expected to reach a value of USD 3.1 billion by 2025, based on a new report by Grand View Research, Inc. The cochlear implants market is anticipated to witness significant growth during the forecast period, which can be attributed to a favorable reimbursement scenario, rising awareness about hearing aids, and increasing adoption of implants. Furthermore, tech …
- カナダの心臓血管外科用機器市場見通し（～2021）Canada Cardiovascular Surgery Outlook to 2021 Summary GlobalData’s new report, "Canada Cardiovascular Surgery Outlook to 2021", provides key procedures data on the Canada Cardiovascular Surgery. The report provides procedure volumes within market segments - Coronary Artery Bypass Graft (CABG) Procedures and Isolated Valve Procedures. The data in the report is derived from dynamic market forecast m …
- 糖尿病治療薬の世界市場2017-2021About Diabetic Therapeutic The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year. Technavio’s …
- 世界のデータセンターVOD市場動向（2012-2016）TechNavio's analysts forecast the Global Data Center Video on Demand (VOD) market to grow at a CAGR of 13.87 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for HD programming and on-demand content. The Global Data Center VOD market has also been witnessing innovation in server technology. However, inefficient streaming of VOD c …
- OLEDディスプレイの世界市場2017-2021About OLED DisplayOLED is a carbon-based diode, which produces light when electricity is passed through the conductors. OLED is a display technology that provides superior picture quality than LCD. The technology used in OLED display primarily consists of passive and active matrix OLED. Technavio’s analysts forecast the global OLED display market to grow at a CAGR of 21.86% during the period 2017- …
- SCADAの世界市場予測（～2022年）：PLC、RTU（遠隔端末装置）、HMI、通信システム“SCADA market expected to exhibit significant growth potential between 2017 and 2022”The SCADA market is expected to grow at a CAGR of 6.6% between 2017 and 2022 to be worth USD 13.43 billion by 2022. The key driving factors for the growth of the SCADA market are increased demand for industrial mobility for remotely managing the process industry, increasing adoption of cloud computing in SCADA sys …
- グラフデータベースの世界市場予測（～2023年）Increasing need for better response time and accuracy to discover new data correlations is the key growth driver for the graph database market The graph database market size is expected to grow from USD 821.8 million in 2018 to USD 2,409.1 million by 2023, at a Compound Annual Growth Rate (CAGR) of 24.0% during the forecast period. Some of the key drivers for the graph database market include ente …
- 世界のヘモフィリア市場：Global Hemophilia Market 2014-2018TechNavio's analysts forecast the Global Hemophilia market to grow at a CAGR of 6.07 percent over the period 2013-2018. One of the key factors contributing to this market growth is the development of new hemophilia therapeutics. The Global Hemophilia market has also been witnessing the increase in technological innovations. However, the high cost of hemophilia therapeutics could pose a challenge t …
- 機能性飲料のグローバル市場：新事業機会と戦略Summary “Functional Drinks - Reassessing future potential, determining consumer targets, and delivering credible products” provides a comprehensive overview of the functional drink landscape, analyzing the regulatory and consumer drivers to identify the best opportunities and strategies. The report identifies the primary need states that are driving consumption in five beverage categories - carbon …
- 集団健康管理（PHM）の世界市場予測（～2021年）The population health management market is projected to reach USD 42.54 Billion by 2021 from USD 13.85 Billion in 2016, at a CAGR of 25.2% in the next five years (2016 to 2021). The implementation of the Affordable Care Act (ACA) in the U.S., government support for the prevention of diseases and adoption of HCIT, rising geriatric population and the subsequent increase in the prevalence of chronic …
- Sodium Alpha-Olefin Sulfonateの世界市場Sodium Alpha-Olefin Sulfonate(AOS) (CAS 68439-57-6) Market Research Report 2013 presents comprehensive data on sodium alpha-olefin sulfonate(aos) markets globally and regionally (Europe, Asia, North America etc.) The report includes sodium alpha-olefin sulfonate(aos) description, covers its application areas and related patterns. It overviews sodium alpha-olefin sulfonate(aos) market, names sodium …
- ソフトウェア定義ストレージ（SDS）の世界市場2019-2023Global Software-defined Storage Market: About this market Software-defined storage enables enterprises to increase their storage capacity and offers simplified data management without depending on hardware. Technavio’s software-defined storage market analysis considers sales to the banking, financial services and insurance (BFSI), telecom and IT, government, healthcare, and other segments. Our ana …
- アメリカの麻酔装置・呼吸装置市場United States Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others Summary GlobalData’s new report, "United States Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, …
- 医療用動画の世界市場予測：種類（3D動画、2D動画、4D動画）、治療分野、用途、エンドユーザーThe global medical animation market is expected to reach USD 301.3 Million by 2021 from USD 117.3 Million in 2016, growing at a CAGR of 20.8% from 2016 to 2021. The global medical animation market is segmented on the basis of type, application, therapeutic area, and end user. By type, the market is categorized into 3D animation, 2D animation, 4D animation, and flash animation. The 3D Animation seg …
- 起立性低血圧症治療薬の世界市場2019-2023Global Orthostatic Hypotension Drugs Market 2019-2023: About the Market Orthostatic hypotension is the reduction in systolic blood pressure and can be divided into neurogenic and non-neurogenic forms. Technavio’s orthostatic hypotension drugs market analysis considers sale from midodrine, northera (droxidopa), fludrocortisone, and other drugs. Our analysis also considers the orthostatic hypotensio …
